MMP9 and liver cancer: The DEN/TAA-induced rats with liver cancer that received the complex-loaded MNPs showed improved anticancer potential, effectively exerting anti-inflammatory activity against DEN/TAA-induced hepatocarcinogenesis by reducing TNF-α levels and inhibiting MMP-9 levels by −26.09 and −40.87%, respectively.